Last reviewed: June 6, 2026 Last updated: June 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Table 1: Dopamine-Related Motivational Disruption Across Clinical Conditions Applications in Clinical Practice Patient Assessment and History Taking When evaluating patients with motivation-related concerns, physicians should assess patterns of immediate gratification seeking alongside traditional symptom inventories
If someone hasnt responded as well to semaglutide, tirzepatide is often the next conversation
Vitamin B12 Injection Ships from Canada to US through the available service pathway, with prompt, express shipping used as a logistics option when applicable
The 0.25 mg dose can be used as a cautious restart or practice-based taper floor, but it is not tested long-term maintenance